Good Manufacturing Practice and Good Distribution Practice Consultative Committee

The Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) Consultative Committee discusses the manufacture and wholesale distribution of medicines.

The GMP and GDP Consultative Committee is an informal committee established to discuss matters relating to the manufacture and wholesale distribution of medicines for human use between:

  • the Medicines and Healthcare products Regulatory Agency (MHRA)
  • other governmental departments
  • the devolved administrations
  • relevant trade associations

Minutes and agendas

Meeting: 12 November 2018

(PDF, 84.1KB, 12 pages)

(PDF, 41KB, 2 pages)

Meeting: 2 May 2018

(PDF, 146KB, 2 pages)

(PDF, 176KB, 12 pages)

Meeting: 10 October 2017

(PDF, 205KB, 2 pages)

(PDF, 223KB, 11 pages)

Meeting: 31 March 2017

(PDF, 143KB, 2 pages)

(PDF, 1.02MB, 12 pages)

Meeting: 7 October 2016

(PDF, 58.5KB, 2 pages)

(PDF, 2.01MB, 10 pages)

Meeting: 18 April 2016

(PDF, 1.35MB, 10 pages)

(PDF, 54.6KB, 2 pages)

Meeting: 30 October 2015

(PDF, 14MB, 13 pages)

(PDF, 135KB, 2 pages)

Meeting: 8 May 2015

(PDF, 3.44MB, 11 pages)

(PDF, 53.5KB, 2 pages)

Meeting: 17 October 2014

(PDF, 5.59MB, 12 pages)

(PDF, 134KB, 2 pages)

Contact details

chris.groutides@mhra.gov.uk

Contents